Böserjunge & Zocker Forum: Community User: Böserjunge
LEXINGTON, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced today that the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services, is providing an additional $3.7 million in funding for the multiple-year cost-share contract between BARDA and T2 Biosystems. The total potential BARDA funding if all contract options are exercised is $62.0 million, reflecting a reduction in the scope of work under contract option 3. The additional funding will be used to advance the U.S. clinical trials for the T2Resistance® Panel and T2Biothreat® Panel and file submissions to the U.S. Food and Drug Administration (FDA) for U.S. regulatory clearance.
Mehr zu diesem Wert
|
|
Thema | ||
|---|---|---|---|
| 1 | Böserjunge & Zocker | ||
| 2 | T2 Biosystems |
|
|
Thema | ||
|---|---|---|---|
| 1 | Trading- und Aktien-Chat | ||
| 2 | HauptForum SK HYNIC | -1,09 % | |
| 3 | DRONESHIELD LTD Hauptdiskussion | ±0,00 % | |
| 4 | Strategy B | -1,25 % | |
| 5 | US Tech 100 Hauptdiskussion | -2,46 % | |
| 6 | VONOVIA Hauptdiskussion | -3,35 % | |
| 7 | Iris Energy | -0,44 % | |
| 8 | BYD Hauptdiskussion | +0,10 % | |
| 9 | Circus SE Inhaber-Akt Hauptdiskussion | -0,13 % | |
| 10 | DAX / Germany 40 Hauptdiskussion | -0,31 % | Alle Diskussionen |
|
|
Thema | ||
|---|---|---|---|
| 1 | HauptForum SK HYNIC | -1,09 % | |
| 2 | DRONESHIELD LTD Hauptdiskussion | ±0,00 % | |
| 3 | Strategy B | -1,25 % | |
| 4 | VONOVIA Hauptdiskussion | -3,35 % | |
| 5 | BYD Hauptdiskussion | +0,10 % | |
| 6 | Circus SE Inhaber-Akt Hauptdiskussion | -0,13 % | |
| 7 | Iris Energy | -0,44 % | |
| 8 | Freunde der Telekom | -0,10 % | |
| 9 | Mt Monger Resources Hauptdiskussion | ±0,00 % | |
| 10 | AURA ENERGY Hauptdiskussion | ±0,00 % | Alle Diskussionen |